SCHEMBL14720829

SCHEMBL14720829

CC(=O)N1CC[C](O)CC1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NOTUM Q6P988 2/20 0.45
PTAFR P25105 1/20 0.43
PIK3CD O00329 1/20 0.40
QDPR P09417 2/20 0.40
CASP6 P55212 1/20 0.39
GFER P55789 1/20 0.39
HSP90AA1 P07900 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720564 0.91 CYP1A2 (0.43) CYP1A2TDP1KDM4ESMN1; SMN2NOTUM
SCHEMBL137219 0.79 CYP1A2 (0.50) CYP1A2TDP1KDM4ESMN1; SMN2NOTUM
SCHEMBL2161595 0.79 CYP1A2 (0.50) CYP1A2TDP1KDM4ESMN1; SMN2NOTUM
SCHEMBL11070126 0.79 CYP1A2 (0.50) CYP1A2TDP1KDM4ESMN1; SMN2NOTUM
SCHEMBL23552252 0.77 CYP1A2 (0.48) CYP1A2TDP1KDM4ESMN1; SMN2NOTUM
SCHEMBL14761812 0.77 CYP1A2 (0.48) CYP1A2TDP1KDM4ESMN1; SMN2NOTUM
SCHEMBL1066347 0.77 CYP1A2 (0.48) CYP1A2TDP1KDM4ESMN1; SMN2NOTUM
SCHEMBL860793 0.76 CYP1A2 (0.77) CYP1A2TDP1KDM4ESMN1; SMN2PIK3CD
SCHEMBL37407 0.76
SCHEMBL14407779 0.76 CYP1A2 (0.77) CYP1A2TDP1KDM4ESMN1; SMN2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed